Avadel Pharmaceuticals plc

Contributing Author

Recent Articles by Avadel Pharmaceuticals plc

Jun-16	Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) AVDL GlobeNewswire
Jun-05	Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia AVDL GlobeNewswire
May-29	Avadel Pharmaceuticals to Present New Data on LUMRYZ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025 AVDL GlobeNewswire
May-29	Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference AVDL GlobeNewswire
May-13	Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer AVDL GlobeNewswire
May-13	Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference AVDL GlobeNewswire
May-08	Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) AVDL GlobeNewswire
May-07	Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance AVDL GlobeNewswire
May-06	Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction AVDL GlobeNewswire